Osteopontin And Integrin Alpha V Beta 3 Expression During The Implantation Window In Ivf Patients With Elevated Serum Progesterone And Oestradiol Level
Z. He,Y. Ma,L. Li,J. Liu,H. Yang,C. Chen,N. Lin,Y. Bai,R. Ma,R. Li,Z. Wu,J. Qiao
DOI: https://doi.org/10.1055/s-0041-111697
2016-01-01
Geburtshilfe und Frauenheilkunde
Abstract:Background: To explore whether endometrial receptivity is determined by osteopontin (OPN) and integrin avp3 expression in women with elevated serum progesterone (P) and/or oestradiol (E2) who are undergoing in vitro fertilisation (IVF). Methods: According to serum hormone levels on the day of I-ICC administration, 33 infertile women were divided into 3 groups: the high E2, high P, and high E2 and P groups. The control group included 11 fertile, healthy women. Endometrial biopsy was performed on ovulation day + 7 to + 8 for all study participants, and the mRNA and protein expression levels of OPN and integrin aV beta 13 were analyzed,Result: No statistically significant differences regarding OPN and integrin avp3 expression were found between infertile patients in the high P. high E2, high E2 and P and control groups. There was no significant correlation between OPN and integrin avp3 staining intensity during the implantation window biopsy in any of the groups studied,``Conclusion: Endometrial OPN and integrant avp3 expression/co-expression is not impaired during the window of implantation in patients with high P. high E2, or high E2 and P levels. The clinical value of assessing endometrial receptivity with OPN and integrin avp3 seems to be uncertain,